Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01225055 · ClinicalTrials.gov registry record · Phase 2
Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury
A Phase 2 study, sponsored by Thomas J. Schnitzer.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT01225055 is a Phase 2 study that has completed, run by Thomas J. Schnitzer. The registered enrollment target is 60 participants.
The verdict
NCT01225055, a Phase 2 study, has completed, sponsored by Thomas J. Schnitzer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
Spinal cord injury (SCI) results in marked acute loss of bone. This study evaluates the effect of teriparatide (PTH) and the use of vibration as a form of mechanical stimulation on bone mass.
Interventions
- DRUG Teriparatide
- DEVICE vibration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2010-10 |
| Est. Completion | 2016-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01225055
The ClinicalTrials.gov registry entry for NCT01225055 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas J. Schnitzer, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Teriparatide is the first listed.
NCT01225055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01225055 about?
NCT01225055 is a clinical study titled "Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury". Spinal cord injury (SCI) results in marked acute loss of bone. This study evaluates the effect of teriparatide (PTH) and the use of vibration as a form of mechanical stimulation on bone mass.
What is the current status of trial NCT01225055?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2010-10. Estimated completion is 2016-08.
What interventions are being tested in trial NCT01225055?
The interventions under investigation include: Teriparatide (DRUG), vibration (DEVICE).
Who is sponsoring clinical trial NCT01225055?
This trial is sponsored by Thomas J. Schnitzer, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.